Uncategorised - European Medical Journal

GLP-1 Receptor Agonists Tied to Increased Fracture Risks in Elderly: WCO 2025

New data suggest that elderly individuals with type 2 diabetes who initiate GLP-1 receptor agonist therapy may face a slightly higher risk of bone fractures compared to those using other common diabetes

Does Smoking Help with Ulcerative Colitis?

Smoking may reduce the risk of developing ulcerative colitis and alleviate disease severity in existing cases.

Exclusive E-Cigarette Use Linked to Lung and Blood Pressure Risks

A new longitudinal study from the All of Us Research Program sheds light on the potential cardiometabolic consequences of exclusive e-cigarette use and dual tobacco use in adults across the United States.

Low-Dose Aspirin Found Safe for Pregnant Patients With Inflammatory Bowel Disease

Pregnant individuals with IBD prescribed low-dose aspirin were no more likely to experience flares than those not on aspirin, according to a new study, easing concerns about its use in this high-risk population.

Inside the Hidden Threat of CNS Infections After Kidney Transplant

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term neurological impact, with metagenomic sequencing crucial for diagnosis.

Clinical Advancements in Becker Muscular Dystrophy

Becker is a serious, progressive muscular dystrophy that presents predominantly in males due to an X-linked…

Emerging Resistance to Newest Antibiotic Ceftazidime/Avibactam

Ceftazidime/avibactam, a key antimicrobial against multidrug-resistant Gram-negative pathogens, has seen increasing use across England since its 2017 launch.

Spotlight on Sebum Production

A recent study found that clascoterone cream 1% significantly reduces sebum production in patients with mild-to-moderate acne, suggesting…

FDA Fast Track Therapy Targets HER2-Mutated NSCLC: AACR 2025

Promising new data emerged on zongertinib, an investigational oral therapy targeting HER2 mutations in advanced non-small cell lung cancer (NSCLC), was presented at the AACR Annual Meeting 2025 in Chicago.

Are JAK Inhibitors Raising VTE Risk in Rheumatoid Arthritis?

In patients with rheumatoid arthritis (RA), understanding the risk of venous thromboembolism (VTE) is increasingly important as treatment strategies evolve.